Lila Biologics Founder’s Journey From Rural India to Turning ‘Science Fiction’ Into Drug Candidates

Seattle-based Lila Biologics, co-founded in 2023 by Anindya Roy, harnesses AI-powered protein design technology from the Baker Lab to develop advanced medical therapies. Roy’s journey began in rural India, driven by a love of science that led him from the University of Calcutta to a University of Washington postdoc with Nobel laureate David Baker, PhD, earning admiration for his innovation and integrity.